Numinus has announced that it is set to expand its psychedelics research laboratory via the development of a building next to their existing lab. The Vancouver-based company hopes the new facility will enhance their IP and partnership strategy, as well as enhancing their analytic testing and contract research revenue streams. The new lab space will also be used to accelerate Numinus’ work in…


Previous articlePT234 – Christopher Solomon – Salvia as a Therapist
Next articleCybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and Nomination of Two Deuterated Candidates for Full IND Enabling Studies Based on Second Milestone Achievement Pursuant to the Adelia Acquisition